List Title | APhA DrugInfoLine

Gastroenterology

SORT BY: Most Recent Most Viewed

September 1, 2003

Drug-Induced Hepatotoxicity: Abrupt Onset, Idiosyncrasies Limit Options

READ

PREVIEW
While medical science has generated much information about the nature and causes of hepatotoxicity secondary to medications or herbal agents, clinicians have few viable options when it comes to...
July 1, 2003

Prilosec OTC Approved for Frequent Heartburn

READ

PREVIEW
A newly defined disorder, frequent heartburn, is the FDA-approved indication for nonprescription omeprazole magnesium (Prilosec OTC—Procter & Gamble). As part of this approval, FDA has...
April 1, 2003

Crohn’s Disease: Immunogenicity of Infliximab Requires Attention

READ

PREVIEW
Administration of single induction doses of infliximab (Remicade—Centocor) at times when patients with Crohn’s disease are not on immunosuppressive agents can lead to development of...
February 1, 2003

GERD: Most Patients Can Be Treated with OTC Medications Alone

READ

PREVIEW
The central role played by pharmacists in the recognition and management of gastroesophageal reflux disease (GERD) is emphasized in a report recently published by the American...
October 1, 2002

FDA Approves New Medication for Hepatitis B

READ

PREVIEW
The approval of adefovir dipivoxil (Hepsera—Gilead) offers patients with chronic hepatitis B a much-needed therapeutic option.

Pages

Medication Monitor

RSS Follow Medication Monitor on Twitter Follow APhA Druginfoline on Twitter

2215 Constitution Avenue NW, Washington, DC 20037 Telephone 202-628-4410 Fax 202-783-2351

© 2013 American Pharmacists Association All Rights Reserved.

About the American
Pharmacists Association

The American Pharmacists Association (APhA) is the organization whose members are recognized in society as essential in all patient care settings for optimal medication use that improves health, wellness and quality of life. Through information, education and advocacy, APhA empowers its members to improve medication use and advance patient care.

About APhA DrugInfoLine

APhA DrugInfoLine (ISSN 2162-3015) is a weekly publication of, and is owned and copyrighted by the American Pharmacists Association, the national professional society of pharmacists. Materials in APhA DrugInfoLine do not neccessarily represent the policy, recommendations, or endorsement of APhA. The publisher, authors, editors, reviewers, and contributors have taken care to ensure that the information contained in APhA DrugInfoLine is accurate and current; however, they shall have no ability to any person or entity with regard to claims, losses, or damage caused or alleged to be caused, directly or indirectly by use of any information contained in the publication. All decisions about drug therapy must be based on independent judgement of the clinician.